HomeCompareNCBDF vs JNJ

NCBDF vs JNJ: Dividend Comparison 2026

NCBDF yields 1.57% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $1.4K in total portfolio value· pulled ahead in Year 10
10 years
NCBDF
NCBDF
● Live price
1.57%
Share price
$25.68
Annual div
$0.40
5Y div CAGR
24.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.1K
Annual income
$1,955.80
Full NCBDF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — NCBDF vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNCBDFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NCBDF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NCBDF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NCBDF
Annual income on $10K today (after 15% tax)
$133.76/yr
After 10yr DRIP, annual income (after tax)
$1,662.43/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $2,374.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NCBDF + JNJ for your $10,000?

NCBDF: 50%JNJ: 50%
100% JNJ50/50100% NCBDF
Portfolio after 10yr
$29.8K
Annual income
$3,352.84/yr
Blended yield
11.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NCBDF
No analyst data
Altman Z
8.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NCBDF buys
0
JNJ buys
0
No recent congressional trades found for NCBDF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNCBDFJNJ
Forward yield1.57%2.14%
Annual dividend / share$0.40$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR24.6%28%
Portfolio after 10y$29.1K$30.5K
Annual income after 10y$1,955.80$4,749.88
Total dividends collected$7.8K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NCBDF vs JNJ ($10,000, DRIP)

YearNCBDF PortfolioNCBDF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,896$196.08$10,594$274.49+$302.00NCBDF
2$11,908$248.79$11,294$360.69+$614.00NCBDF
3$13,058$316.60$12,133$476.91+$925.00NCBDF
4$14,376$404.29$13,156$635.42+$1.2KNCBDF
5$15,901$518.32$14,432$854.61+$1.5KNCBDF
6$17,681$667.59$16,056$1,162.76+$1.6KNCBDF
7$19,783$864.46$18,175$1,604.53+$1.6KNCBDF
8$22,295$1,126.33$21,009$2,252.68+$1.3KNCBDF
9$25,333$1,478.08$24,911$3,229.73+$422.00NCBDF
10← crossover$29,062$1,955.80$30,458$4,749.88$1.4KJNJ

NCBDF vs JNJ: Complete Analysis 2026

NCBDFStock

BANDAI NAMCO Holdings Inc. develops entertainment-related products and services worldwide. Its Toys and Hobby segment offers toys, capsule and candy toys, cards, confectionery, food, apparel, sundries, plastic models, figures, communications and peripheral equipment, consumer electronics, character-based products, pachinko and pachislot machines, medical and electronic-related equipment, playground equipment, bicycles, furniture, visual, RC and robot toys, molds, stationery, prizes, and other products. This segment is also involved in the contract operations for inspecting and testing; and import and export of toys, etc. The company's Network Entertainment segment plans, develops, and distributes network content, as well as home video games, live events, machines, Internet-based online games, other software and services, amusement machines, etc.; and provides advertising, promotion, online video distribution and games platforms, communication and related tools, and shared services, as well as visual substrates. Its Real Entertainment segment plans, produces, and sells amusement machines; plans and operates amusement facilities, etc.; and provides after-sales services and stocks and sells pre-owned amusement machines and products. The company's Visual and Music Production segment offers visual and music content and package software, and audio engineering services; conducts live entertainment operations; plans and produces animation; manages affiliated artists; operates fan clubs; produces visual products related to live performances, events, and music; plans, produces, and sells goods, tickets, etc. Its IP Creation segment plans and produces animations, labels, events, etc., as well as music related to animations; manages and administers copyrights and other rights. The company was formerly known as NAMCO BANDAI Holdings, Inc. and changed its name to BANDAI NAMCO Holdings Inc. in June 2014. The company was founded in 2005 and is headquartered in Tokyo, Japan.

Full NCBDF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NCBDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NCBDF vs SCHDNCBDF vs JEPINCBDF vs ONCBDF vs KONCBDF vs MAINNCBDF vs ABBVNCBDF vs MRKNCBDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.